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UMass Medical School, Worcester, MA 01605, USA.Entamoeba histolytica possesses a family of approximately 100 putative transmembrane kinases (TMKs),
indicating that the parasite has an extensive means of environmental sensing. The TMKs have been
divided into nine sub-groups based on the sequence composition of their intracellular kinase as well
as extracellular cysteine-rich domains. EhTMKB1-9 has been recently shown to be expressed in prolifer-
ating trophozoites and induced by serum. Interference with EhTMKB1-9 by antisense RNA knockdown or
expression of a truncated protein diminished proliferation, adhesion and cytotoxicity. Here we report the
involvement of EhTMKB1-9 in phagocytosis and its virulence function in the formation of amebic colitis.
Trophozoites induced to express higher levels of wild type EhTMKB1-9 showed increased capacity for
endocytosis. In contrast, cells compromised for the EhTMKB1-9 expression through antisense inhibition
showed signiﬁcantly lower levels of phagocytosis and endocytosis under the experimental conditions.
The role of EhTMKB1-9 as a virulence factor was studied using animal models of amebiasis. Trophozoites
expressing high levels of mutant protein lacking the kinase domain showed a competitive disadvantage
with regard to survival as well as invasive phenotype in the murine model of amebic colitis. The same
parasites however, were not compromised in their ability to generate abscess in the gerbil model of inva-
sive liver amebiasis. EhTMKB1-9 is the second member from the ‘‘B’’ group of EhTMKs which seems to be
deployed by the parasite during intestinal infection. TMKs are attractive targets for drug development
because of their requirement in virulence and proliferation.
 2012 Australian Society for Parasitology Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Entamoeba histolytica, the causative agent of amebiasis, is a pro-
tozoan parasite and responsible for severe morbidity and almost
100,000 deaths worldwide (Haque et al., 2003; Petri et al., 2009).
After Plasmodium spp., E. histolytica is estimated to be the second
major leading cause of deaths due to a protozoan parasite. It is
therefore important to understand the virulence factors involved
in the production of invasive disease in order to identify novel drug
targets to treat this parasitic infection.
The parasite exhibits a biphasic life cycle consisting of non-
motile, transmissible cysts and motile, replicating, invadingPublished by Elsevier Ltd.
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Open actrophozoites. Humans are the only natural host. E. histolytica infec-
tion can produce colitis characterized by ulceration and invasion of
the intestinal wall. In advanced cases, trophozoites spread to dis-
tant organs including liver, lungs and brain (Samuel L, 2003). Cytol-
ysis and phagocytosis of the target cell is a major pathological
feature of the disease and therefore the factors contributing to
cytolysis are important to understand amebic invasion.
Trophozoites have been demonstrated to persist in humans for
many months, which suggest that they are able to evade the im-
mune system (Haque et al., 2002). E. histolytica transmembrane ki-
nases (EhTMKs) were initially thought to be involved in antigenic
variation, as some of them showed similarity to the variant speciﬁc
surface protein (VSP) of Giardia lamblia (Beck et al., 2005). Recent
studies however favor the role of EhTMKs as principal signaling
molecules, especially at the parasite-host interface (Buss et al.,
2010). Similar to metazoan counterparts, many of the EhTMKs
characterized so far (including PATMK, TMK39 and EhTMKB1-9)
show cysteine-rich extracellular domains containing furin like or
epidermal growth factor (EGF) -like moieties. These are signature
extracellular domains in metazoan TMKs and are thought to be in-
volved in aggregation of TMKs. E. histolytica survives in a complexcess under CC BY-NC-ND license.
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and space, and may need to sense changes in the environment in
order to escape the host defense mechanisms, trigger transition
to the persistent and environmentally resistant infective cyst life
stage and express the proteins important for virulence and tissue
invasion. This demands a repertoire of highly specialized network-
ing of signaling pathways.
Transmembrane kinases represent one of the major classes of
cell surface receptors and are involved in essential cellular pro-
cesses in almost all the eukaryotic cells. These molecules typically
sense environmental cues and transduce the signals to appropriate
intracellular pathways. Completion of sequenced genomes of hu-
man-infective as well as non-infective protozoa in recent years
has allowed the kinome of the parasites to be deﬁned (Naula
et al., 2005). Bioinformatic analysis predicts at least 90 TMKs in
E. histolytica, 9 in Dictyostelium discoideum (Goldberg et al.,
2006); 88 in Monosiga brevicollis (Manning et al., 2008), 11 in Plas-
modium falciparum (Ward et al., 2004) and 10 TMKs in Trypano-
soma brucei (Parsons et al., 2005). An EhTMK typically contains
four domains – N-terminal signal peptide, extracellular domain
rich in CXXC repeats, a single transmembrane helix and an intra-
cellular tyrosine-kinase like domain (Beck et al., 2005). E. histolyti-
ca TMKs have been subdivided into nine sub-groups (A, B1–3, C, D1–
2, E and F) based on their kinase domain as well as sequence com-
position of the extracellular domains.
Many signaling pathways have been shown to be active in E. his-
tolytica andwe hypothesize that these allow the pathogen to appro-
priately respond to various environmental stimuli. The ﬁrst
Entamoeba TMK to be functionally characterized TMK B1.I.1 was
shown to play an active role in E. histolytica cell proliferation (Mehra
et al., 2006). To date four additional EhTMKs have been studied.
PATMK (phagosome associate transmembrane kinase) is also a
member of EhTMK B-family that participated in erythrophagocyto-
sis and was identiﬁed during screening for the proteins involved in
the identiﬁcation and ingestion of apoptotic corpses (Boettner et al.,
2008). Subsequently, it was proven that a single E. histolytica tro-
phozoite could express members of at least four sub-groups (A, B1,
D1 and E) and thus utilize multiple TMKs for non-redundant func-
tions (Buss et al., 2010). TMK-39was shown to regulate the internal-
ization of polyanionic macromolecules; whereas TMK-54 was
shown to be a major growth factor receptor besides regulating the
expression of heavy chain subunit of the Gal/GalNAc surface lectin
(Buss et al., 2010). EhTMKB1-9 (TMK-95) is themost recentmember
of the TMK family to be functionally characterized in detail (Shrimal
et al., 2010). EhTMKB1-9 was found to be serum responsive and one
of the ﬁrst examples of inducible genes in Entamoeba. The kinase do-
mainwas found to have both ser/thr and tyr kinase activities similar
to dual speciﬁcity kinase splA from D. discoidium. Adhesion is one of
the ﬁrst steps in pathogenesis and a prerequisite for host cell killing.
Cells containing reduced levels of EhTMKB1-9 or high levels of dom-
inant negative mutant protein resulted in decreased proliferation,
target cell adherence as well as cell killing. The results clearly
showed that EhTMKB1-9 was an important signaling molecule
likely to be involved in parasite proliferation in vivo.
Protein phosphorylation regulates most aspect of cell life and
protein kinases have been termed as one of the major drug targets
of the twenty-ﬁrst century. Plasmodial kinases have been consid-
ered targets for drug development and, based on structural diver-
gence, selectivity against mammalian kinases have been viewed as
a realistic possibility (Doerig, 2004). Protein kinases also are being
pursued as drug targets in trypanosomes and Leishmania (Naula
et al., 2005).
The objective of the present work was to validate the in vitro
observations using the animal models of amebiasis and to assess
EhTMKB1-9’s pathogenesis properties in view of the previous stud-
ies showing its potential as an important virulence factor. Parasitesoverexpressing the dominant negative mutant protein were tested
for their competence to phagocytose and kill cells as well as cause
infection at two host target tissues- gut and liver. The ability of
parasite to survive and invade the gut was assessed by competition
experiment using the mouse model of amebiasis. Similarly, gerbil
liver abscess model was used to study parasite’s ability to induce
liver abscess. As in case of PATMK, EhTMKB1-9 was found to be
important for intestinal infections but not for causing liver ab-
scesses. The studies further conﬁrm role of EhTMKB1-9 as an
important virulence factor and open up possibilities of screening
molecules which potentially could target this and other similar
extracellular receptors.2. Materials and methods
2.1. Strains and cell culture
E. histolytica strain HM1:IMSS trophozoites were grown under
axenic conditions in TYI-S-33 medium supplemented with 15%
adult bovine serum, 1 Diamond’s vitamins, penicillin (100 U/
ml) and streptomycin (100 lg/ml) (Diamond et al., 1978). The
cloning of full length EhTMKB1-9 (TMK9-S), dominant negative
mutant (TMK9-Dn) and antisense construct (TMK9-AS) into tetra-
cycline inducible expression vector pEhHYG-tetR-O-CAT (TOC) has
been described previously (Shrimal et al., 2010). Please note that
the AS construct was cloned using the ﬁrst 1 kb region of
EhTMKB1-9 ORF. The initial 307 nucleotides are unique to
EhTMKB1-9 while the rest 707 nucleotides share sequence similar-
ity only with another member from the family viz. EhTMKB1-10.
However, the expression of EhTMKB1-10 is at least 1000-fold less
as compared to EhTMKB1-9 as seen by quantitative real time PCR
measurements in normal HM1 proliferating cells (Shrimal et al.,
2010). The transfected lines carrying different constructs were gen-
erated using established protocols (Olvera et al., 1997; Asgharpour
et al., 2005). In short, amebae (2.2  105 ml1) were washed in
Medium 199 (Invitrogen, CA) supplemented with 5.7 mM cysteine,
1 mM ascorbic acid, 25 mM HEPES (pH 6.8) and mixed with 10 lg
of DNA and 30 ll of Superfect (Qiagen). Treated amebae were incu-
bated for 3 h at 37 C, followed by overnight recovery in TYI-S-33
medium at 37 C. Where mentioned, the cultures were induced
using 20 lg/ml tetracycline for 48 h in TYI-33-S medium.
2.2. Murine model of amebic colitis
The murine model of amebic colitis utilized mice carrying two
copies of R allele at codon 223 of the leptin receptor, as described
elsewhere (Stratigopoulos et al., 2009; Duggal et al., 2011). All ani-
mal protocols were approved by the Institutional Animal Care and
Use Committee. Mice were maintained under speciﬁc-pathogen–
free conditions at the University of Virginia and monitored closely
for general well-being. For competition experiments the respective
transfectant lines were mixed in a 1:1 ratio. For all intracecal inoc-
ulations a total of 2  106 trophozoites in log phase were injected
in a volume of 150 ll after laparotomy as described (Houpt et al.,
2002). In mice inoculated with induced amebae, the induction
was maintained by the addition of 0.2 mg/ml doxycycline and 5%
sucrose in drinking water. All mice were sacriﬁced 4 days after
infection. Amebae were isolated from two in vivo locations – the
luminal gut and gut mucosal surface. DNA was extracted and sam-
ples were subjected to construct speciﬁc quantitative PCR.
2.3. Gerbil model of amebic liver abscess formation
Liver abscesses were induced as described (Chadee and Meerov-
itch, 1989). Transfectants carrying either the control or plasmid
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ence or absence of 20 lg/ml tetracycline for 48 h prior to infection.
1  106 similarly treated transfectant lineswere inoculated into dif-
ferent liver lobes of 50–60 day old Mogolian male gerbil (Meriones
unguiculatus). One transfectant was injected into the right anterior
lobe of the liver and the other into left lobe. This order was reversed
in half of the animals. After recovery from surgery, induction was
maintained where appropriate by adding 2 mg/ml doxycycline in
the drinkingwater. Gerbilswere sacriﬁced 7 days past infection, liv-
ers were extracted and abscess weights measured.
2.4. Quantitative PCR
Closed circular DNA was isolated from cecal contents by a mod-
iﬁcation of previously published methods (Pontes et al., 2002;
Sikorski et al., 2002). Amebae were collected and washed with
phosphate-buffered saline (PBS), and lysed by the addition of
700 ll Rapid One-Step Extraction buffer – 10 mM Tris (pH 8.0),
300 mM EDTA (pH 8.0), 1% sodium lauryl sulfate, 1% polyvinylpoly-
pyrrolidone. The lysate was heated to 95 C for 10 min, vortexed
and returned to 95 C for 10 min. The cell lysate was then centri-
fuged at 14,000g for 10 min at room temperature. Five hundred
microliters of the supernatant was collected, mixed with 50 ll of
cold 3 M sodium acetate (pH 5.3, 4 C) and 1 ml of cold ethanol
(20 C), and immediately centrifuged at 14,000g for 15 min.
DNA pellet was washed once with 500 ll of 70% ethanol
(20 C), dried under vacuum, and resuspended in 50 mM MOPS
buffer (50 mM MOPS (morpholinepropanesulfonic acid), 750 mM
NaCl (pH 7.5) to give a ﬁnal volume of 0.75 ml. The sample was
then puriﬁed using the Zymo plasmid puriﬁcation kit (Zymo
Inc.). The eluted DNA was passed twice over a Zymo-Spin IV-HRC
ﬁltration column, and DNA was subjected to PCR with construct
speciﬁc primers. TOC plasmid was detected by using primers spe-
ciﬁc for the chloamphenicol acetyl transferase (CAT) gene. The
primers used were – forward 50-TGGAGTGAATACCACGACGA-30
and reverse 50-GGGCGAAGAAGTTGTCCATA-30. The TMK9-Dn
expression plasmid was detected by using the following pair of
primers: forward 50-ATTGAAGGAGGATATGCATGTGA-30 and re-
verse 50-TGATGATGATGATGATGTGATCC-30.
2.5. Erythrophagocytosis assay
The assay was performed as described (Mora-Galindo et al.,
1997). Brieﬂy, trophozoites and red blood cells were mixed to-
gether at a ratio of 1:100, pelleted down and washed three times
with distilled water to burst open non-engulfed RBCs. The pellets
containing parasites and ingested RBCs were lysed in concentrated
formic acid (90%), and solutions were read on a spectrophotometer
at 400 nm.
2.6. RITC-dextran uptake assay
Endocytosis assay to quantitate uptake of RITC-dextran was
performed as described (Sahoo et al., 2004). Brieﬂy, trophozoites
and RITC-dextran were incubated together for 30 min at 36 C pel-
leted down and washed three times with PBS. The cells were lysed
by resuspending in PBS containing triton-X100 and ﬂuorescence
was measured.3. Results
3.1. EhTMKB1-9 enhances erythrophagocytosis and endocytosis
Erythrophagocytosis is one of the common assays used to assess
virulence potential of laboratory strains of Entamoeba. Differencein the ability of pathogenic E. histolytica strains to ingest erythro-
cytes compared to the nonpathogenic species Entamoeba dispar
has been used historically to diagnose Entamoeba infections from
stool specimen (Trissl et al., 1978). Both the amebic Gal/GalNAc
inhibitable lectin as well as transmembrane kinases have been
shown to be important in mediating the attachment of ameba to
erythrocytes (Petri et al., 1987; Boettner et al., 2008). EhTMKB1-9
has been previously shown to constitute about 95% of the total ex-
pressed B1 family TMKs and to be important in adhesion as well as
destruction of CHO cells (Shrimal et al., 2010). We measured the
ability of trophozoites overexpressing or deﬁcient in EhTMKB1-9
to phagocytose red blood cells. Parasites grown in absence or pres-
ence of tetracycline were incubated with the red blood cells and
extracellular erythrocytes were lysed in distilled water. Parasites
containing ingested erythrocytes were then lysed in concentrated
formic acid and the amount of heme present (as measured by
OD) was used as a surrogate marker for the quantiﬁcation of
ingested erythrocytes. The cells containing vector alone, or the
sense construct for over-expression, did not show any signiﬁcant
change in erythrophagocytosis. Over expression of the dominant
negative mutant (TMK9-Dn) or antisense RNA showed a signiﬁcant
reduction in phagocytosis (Fig. 1A).
To determine the role of EhTMKB1-9 in a general endocytosis
pathway, we measured the uptake of a 10-kDa ﬂuid-phase marker
RITC-dextran. The cells containing vector alone did not show any
signiﬁcant change in uptake in the presence or the absence of tet-
racycline. Trophozoites induced to over express the full length
EhTMKB1-9 showed signiﬁcantly higher ﬂuorescence indicating
increased endocytosis activity (Fig. 1B), whereas cells induced to
over express the antisense RNA showed reduced endocytosis. Sur-
prisingly, cells induced to express the dominant negative mutant
protein showed no change in the endocytic activity. The results
suggested that the level of endocytosis is reduced only by anti-
sense inhibition of EhTMKB1-9 gene expression. This could indi-
cate a greater role for the extracellular domain rather than the
kinase domain of EhTMKB1-9 in endocytosis.
3.2. Expression of dominant negative EhTMKB1-9 mutant confers
competitive disadvantage to amebae in host gut
To test if EhTMKB1-9 acts as a virulence factor in establishing
an invasive intestinal infection we used a murine model of amebic
colitis (Guo et al., 2011). LepR Q223R mice were infected intrace-
cally with a 1:1 mixture of amebae induced to express dominant
negative EhTMKB1-9 and vector backbone. As a control, another
set was used with a 1:1 mixed uninduced amebae. Amebae were
induced for 48 h with 20 lg/ml tetracycline wherever indicated
before animal inoculations. Eight mice were infected in each group.
All mice were sacriﬁced 4 days post-inoculation and trophozoites
were recovered from two different locations. Those isolated from
the cecal contents were considered luminal whereas those re-
moved from the luminal surface of the cecum by scraping were
considered mucosal (Gilchrist et al., 2010). Closed circular DNA
was extracted as described under materials and methods and used
for quantitative PCR analysis. Construct-speciﬁc primer pairs al-
lowed us to compare surviving populations of mutant or the con-
trol trophozoites quantitatively. The ratio of cultured input
amebae in the induced or uninduced sets was used to correct the
qPCR ratio of dominant negative to vector from each set of mice.
The ratio of TMK9-Dn to TOC vector was signiﬁcantly lower in
the case of luminal amebae (p < 0.01) as well as mucosal amebae
(p < 0.01) (Fig. 2). This indicated that the number of TMK9-Dn
expressing amebae decreased substantially at both the gut loca-
tions. This was consistent with them having a competitive disad-
vantage in the gut environment. In contrast the ratio of TMK9-Dn
to TOC vector were comparable when these parasites were mixed
Fig. 1. Role of EhTMKB1-9 in phagocytosis and pinocytosis. Expression of the transfectants was uninduced (grey bars) or induced (black bars) with 20 lg/ml tetracycline for
48 h. (A) Quantiﬁcation of erythrophagocytosis in cells showing over-expression or suppression of EhTMKB1-9. Trophozoites were incubated with RBCs for 10 min at 37 C
followed by lysis of adherent RBCs with chilled water. The trophozoites with phagocytosed RBCs were then lysed using formic acid and amount of heme released was
quantitated by measuring absorbance at 400 nm. The values are expressed as an average of three independent experiments ±SD. (B) Quantiﬁcation of liquid phase pinocytosis.
The different transfectants were incubated with 2 mg/ml RITC-dextran in PBS for 30 min and subjected to quantitative estimation by spectroﬂuorometer. The values are
expressed as an average of three independent experiments ±SD. Abbreviations: TOC – tetracycline inducible vector control; TMK9 S – construct expressing full length
EhTMKB1-9; TMK9 Dn – construct expressing kinase domain deletion mutant of EhTMKB1-9; TMK9 AS – construct expressing antisense RNA to N-terminal 1 kb region of
EhTMKB1-9. ⁄p value <0.05; ⁄⁄p value <0.001.
Fig. 2. Competitive disadvantage of amebae expressing the dominant negative
TMKB1-9 protein in the murine model of amebic colitis. Amebae were induced for
48 h with 20 lg/ml tetracycline where indicated. Mice carrying the susceptible
Q223R Lepr allele were infected intracecally with induced TOC and TMK9-Dn
amebae mixed in a 1:1 ratio. As a control, an equal number of mice were infected
with the mixture of uninduced ameba. Induction was maintained by the addition of
0.2 mg/ml doxycycline and 5% sucrose in drinking water post-infectious challenge
as appropriate. All mice were sacriﬁced 4 days after infection, and the ratios of the
TMK9-Dn to the control TOC vector were determined by construct speciﬁc qPCR in
amebae isolated from two different in vivo locations – the luminal gut (luminal) or
the gut surface (mucosal). Values were corrected by the input data, and statistical
signiﬁcance was determined using t test. The difference in ratio was statistically
signiﬁcant in the luminal as well as mucosal samples (p < 0.01).
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(data not shown), suggesting that the decrease in proliferation
and invasion upon TMK9-Dn expression was unique to the intesti-
nal lumen.3.3. EhTMKB1-9 is not essential for amebic liver abscess formation
We also tested if EhTMKB1-9 which seemed to be important for
intestinal amebiasis played any role in liver infection. We used the
gerbil model of amebic liver abscess formation. Amebae carrying
TMK9-Dn or TOC construct were grown in presence or absence of
tetracycline for 48 h prior to inoculations. One million trophozoites
each from similarly treated groups were used to inoculate different
liver lobes of the same animal. The order in which the transfectants
were inoculated was reversed in half of the animals to avoid any
potential bias regarding the site of infection. Eight animals were
used in each group. Gerbils were sacriﬁced 4 days post-infection,
livers were isolated and abscess weights measured. Amebae from
abscesses were cultured in TYI-S-33 broth to conﬁrm infections
(data not shown). No signiﬁcant difference was noticed between
the uninduced and induced control (Fig. 3A) or TMK9-Dn express-
ing (Fig. 3B) amebae as indicated by similar abscess weights. We
concluded that expression of EhTMKB1-9 did not appear essential
for liver infection.
TMK9-Dn transfectants in general caused smaller abscesses
irrespective of the induction state. The difference in abscess
weights was statistically signiﬁcant between the induced TOC
and TMK9-Dn transfectants (p < 0.005). This is not totally unex-
pected as full length TMKB1-9 has been shown to be important
for cell proliferation (Shrimal et al., 2010). Surprisingly, the differ-
ence was also signiﬁcant between the uninduced transfectants
lines after removing the only outlier in the TMKDn group using
Grubb’s test. This most likely is due to TMK9-Dn background
expression from the vector (Hamann et al., 1997) which in turn
could be interfering with the wild type TMK function. This further
emphasizes EhTMKB1-9’s role in proliferation in vivo.
4. Discussion
EhTMKB1-9 is a virulence factor important for amebic colitis.
Expression of the mutant EhTMKB1-9 conferred a disadvantage
on the survival and invasive properties of amebae in the intestine.
Competition experiment gave a direct proof for the role of
EhTMKB1-9 in invasive disease as well as survival inside host
Fig. 3. Induction of the EhTMKB1-9 dominant negative mutant did not affect liver abscess formation: Amebae transfected with the control vector or the plasmid expressing
kinase domain deletion mutant of EhTMKB1-9 were grown in presence or absence of 20 lg/ml tetracycline for 48 h prior to infection. Amebae (106) were inoculated into
different liver lobes of 50–60 day old Mongolian male gerbils. Induction was maintained where appropriate by adding 2 mg/ml doxycycline in the drinking water. Gerbils
were sacriﬁced 7 days after infection, livers extracted and abscess weights measured. (A) Comparison between abscess weights formed by uninduced or induced vector
transfectants (B) comparison between abscess weights formed by uninduced or induced EhTMKB9-Dn transfectants. The X-axis shows transfectant line and treatment
whereas the Y-axis represents abscess weight.
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infection. Expression of EhTMK9-Dn mutant did not show any sig-
niﬁcant effect in the degree of abscess formation as seen by the
comparison between abscess weights of induced EhTMK9-Dn ver-
sus control transfectants. E. histolytica seems to employ different
virulence factors in different environments.
Formation of colitis and liver abscess appear to require some
distinct virulence factors. Silencing of amoebapore A impaired par-
asite’s ability to cause liver abscess but did not affect its ability to
cause tissue destruction in a colonic xenograft model of amebiasis
(Zhang et al., 2004). Over expression of cysteine protease-2 re-
duced in vitro monolayer destruction but had no effect on liver ab-
scess formation (Hellberg et al., 2001). In our previous work we
had discovered that the phagosome associated TMK (PATMK)
was also important in the establishment of gut but not liver infec-
tions. We conclude that the virulence program required by
E. histolytica for a successful intestinal infection differs from that
required for liver infection.
It has been proposed that rapid phagocytosis of host cells might
give E. histolytica an advantage for persistence in human gut by
clearing dead cells and preventing release of host immunomodula-
tory signals which in turn could elicit inﬁltration of inﬂammatory
cells (Boettner et al., 2008). PATMK participated in erythrophago-
cytosis (Boettner et al., 2008). Downregulation with shRNAs or
expression of C terminal deletion mutant of PATMK, both de-
creased erythrophagocytosis by P50%. Expression of PATMK mu-
tant also reduced the infection rate by 30% in mouse model of
colitis. Consistent with this, EhTMKB1-9 also seemed to play a role
in phagocytosis and endocytosis. In the present studies, the effect
of down regulating of EhTMKB1-9 was not as dramatic compared
to the downregulation of PATMK. Phagocytosis and endocytosis as-
says showed a 630% decrease. It is likely that EhTMKB1-9 may not
be the primary receptor for the red blood cells and may be partic-
ipating in the process as a non-receptor accessory molecule. Previ-
ous studies support this observation as no speciﬁc enrichment was
seen for EhTMKB1-9 in phagocytic cups during erythrophagocyto-
sis (Somlata et al., 2011). One of the observations made during the
course of this study was that the antisense RNA against EhTMKB1-
9 affected endocytosis but expression of kinase deletion mutant
did not. It is possible that EhTMKB1-9 lacking the kinase domain
could function similar to the epidermal growth factor receptor(ErbB) family proteins present in mammalian cells. Each ErbB
member does not have an active kinase domain, but it can activate
the relevant pathway through ligand induced hetero-dimerization
with its partner with an active kinase domain (Linggi and Carpen-
ter, 2006). This could explain the negative effect on endocytosis
only after downregulation of the full length molecule.
Expression of TMK9-Dn showed impairment in multiple viru-
lence functions including proliferation, adhesion, phagocytosis
and target cell destruction (Shrimal et al., 2010 and this study). It
is very important that the parasites maintain all these virulence
functions in order to divide in gut environment, where the cells
are constantly being washed away and replaced. The inability of
TMK9-Dn cells to survive in the gut as suggested by the competi-
tion experiment indicates key role for EhTMKB1-9 in intestinal
infection. It is possible that the parasite relies on a major virulence
factor for tissue speciﬁc infection but has backup factors with over-
lapping functions as any interference with this may help the host
to develop better immune response and hence clearance of infec-
tion. Although both EhTMKB1-9 and PATMK are important for
intestinal infection, their inﬂuences on phagocytosis differ signiﬁ-
cantly. It is possible that the TMKs belonging to the same group
(but different subgroups) may have retained the ability to carry
redundant functions to some extent as this would ensure estab-
lishment of the parasite in its only natural host.
It would be interesting to quantitate expression of different
members from the same group involved in intestinal infection
in vivo. This could be done by developing antibodies to conserved
regions of the closely related members and such a group of TMK
proteins could also serve as an attractive target for drug design.
It is remains to be discovered what ligands stimulate EhTMKB1-9
and the mechanism through which EhTMKs transduce signals
intracellularly. It would also be important to see if EhTMKB1-9
modulates the amebic surface lectins since adherence is decreased.
Given the essential role EhTMKs play in the onset of infection,
the idea of targeting EhTMKs as a therapeutic strategy is a promis-
ing one. Protein kinases have become the second most important
group of drug targets after G-protein-coupled receptors, due to
their important roles in parasite proliferation and establishment
of invasive disease (Cohen, 2002). It has been proposed that protein
kinases, which have less than 60% sequence identity to human
counterparts, could be speciﬁcally inhibited (Vieth et al., 2004;
248 M.M. Abhyankar et al. / International Journal for Parasitology: Drugs and Drug Resistance 2 (2012) 243–248Naula et al., 2005). Most of the protozoan protein kinases and their
putative homologues in higher eukaryotes rarely show P60%
homology (Doerig et al., 2002) and hence these could be ideal can-
didates for drug design. This concept was validated for trypanoso-
matids, where the target Leishmania CDK3 which had 54% identity
to human counterpart was inhibited efﬁciently and speciﬁcally by
the designed inhibitor (Grant et al., 2004). In our work we have
identiﬁed two EhTMKs belonging to the same family that are in-
volved in non-redundant functions including cell phagocytosis
and colitis. Development of inhibitor molecules that target closely
related EhTMKs within a family might be advantageous. Future
experiments would be directed to see the role of multiple TMKs
simultaneously in the intestinal virulence program of E. histolytica.Acknowledgement
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